Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain

Journal of Acquired Immune Deficiency Syndromes

Volumn 27, Issue 1, 2001, Pages 35-43

  Benito, Natividad ^a   Rañó, Ana ^a   Moreno, Asunción ^a   González, Julià ^a   Luna, Montserrat ^a   Agustí, Carlos ^a   Danés, Cristina ^a   Pumarola, Tomás ^a   Miró, José María ^a   Torres, Antoni ^a   Gatell, José María ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Acquired immunodeficiency syndrome; HIV infections; Lung diseases; Pneumonia; Pulmonary infiltrates

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BLOOD CULTURE; BRONCHOSCOPY; CLINICAL TRIAL; CYTOMEGALOVIRUS; DIAGNOSTIC PROCEDURE; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INCIDENCE; LEGIONELLA; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOBACTERIOSIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; SEROLOGY; SPAIN; SPUTUM CULTURE; THORAX RADIOGRAPHY; VIRUS PNEUMONIA;

EID: 0035329588     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200105010-00006     Document Type: Article

References (46)

1. HIV-associated respiratory diseases
2. Autopsy findings in HIV-infected inner city patients
3. Changes in pathological findings at autopsy in AIDS cases for the last 15 years
4. Respiratory illness in persons with human immunodeficiency virus infection
5. Respiratory disease trends in the pulmonary complications of HIV infection study cohort
6. Pulmonary complications of HIV infection in Dar es Salaam, Tanzania. Role of bronchoscopy and bronchoalveolar lavage
7. Bronchoscopic and other invasive sampling techniques in the diagnosis of pulmonary complications of HIV infection
8. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus
9. Update trend in AIDS incidence 1996
10. Impact of combination therapy for HIV infection on inpatient census
11. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
12. Opportunistic infections occurring during highly active antiretroviral treatment
13. Natural history of HIV infection in the era of combination antiretroviral therapy
14. Microscopic and bacteriologic analysis of expectorated sputum
15. Pulmonary complications of the acquired immunodeficiency syndrome: Report of National Heart, Lung and Blood Institute workshop
16. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome
17. Bacterial pneumonia in patients with the acquired immunodeficiency syndrome
18. Survival differences in European AIDS patients 1979-1989
19. Factors associated with the development of Pneumocystis carinii pneumonia in 5025 European patients with AIDS
20. Regional differences in use of antiretrovirals and primary prophylaxis in 3,122 European HIV-infected patients
21. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis
22. Trends in the incidence and outcomes defining acquired immunodeficiency syndrome (AIDS) in the multicenter AIDS cohort study: 1985-1999
23. Danish AIDS patients 1988-1993: A recent decline in Pneumocystis carinii pneumonia as AIDS-defining disease related to the period of known HIV positivity
24. Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13
25. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1
26. The prospective study of the pulmonary complications of human immunodeficiency vires infection
27. Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex
28. Bacterial pneumonia in persons infected with the human immunodeficiency virus
29. The impact of potent antiretroviral therapy on the characteristics of hospitalized patients with HIV infection
30. The impact of highly active antiretroviral therapy on HIV-related hospitalizations in 17 county hospitals in Catalonia, Spain
31. Diagnostic value of telescoping plugged catheters in HIV-infected patients with pulmonary infiltrates
32. Mode of presentation and diagnosis of bacterial pneumonia in human immunodeficiency virus-infected patients
33. Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: A clinical, radiological, microbiological and epidemiological study
34. HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy
35. Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-patients after the introduction of highly active antiretroviral therapy
36. Tuberculosis among European patients with the acquired immune deficiency syndrome: The AIDS in Europe Study Group
37. Incidence of tuberculosis in the United States among HIV-infected persons: The Pulmonary Complications of HIV Infection Study Group
38. Lung cancer in patients seropositive for human immunodeficiency virus
39. Lung cancer in association with human immunodeficiency virus infection
40. Aetiology and prognosis factors of patients with AIDS presenting life-threatening acute respiratory failure
41. Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia and severe respiratory failure
42. AIDS-related Pneumocystis carinii pneumonia in the era of adjunctive steroids. Implication of BAL neutrophilia
43. Cost and outcome of intensive care for patients with AIDS. Pneumocystis carinii pneumonia and severe respiratory failure
44. Bacterial pneumonia in HIV-infected patients. Analysis of risk factors and prognosis indicators
45. Empiric outpatient management of HIV-related pneumonia: Economical or unwise?